![Roger Franklin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Franklin
Directeur/Membre du Conseil chez
ABLIVA AB
Profil
Roger Franklin is currently the Director at Abliva AB. He also holds positions as Director at Gesynta Pharma AB, TargED Biopharmaceuticals BV, Crosslanes Holding AB, and Complement Therapeutics GmbH.
Additionally, he is the Deputy Director at HVentures Capital i AB, HVentures Capital II AB, HVentures AB, and Partner at Hadean Ventures AS.
Previously, he worked as Deputy Director at SAGA Diagnostics AB and Analyst at Panmure Liberum Capital Ltd. from 2010 to 2018.
Dr. Franklin obtained an undergraduate degree from the University of Oxford and a doctorate from the University of Cambridge.
Postes actifs de Roger Franklin
| Sociétés | Poste | Début |
|---|---|---|
| ABLIVA AB | Directeur/Membre du Conseil | 20/05/2020 |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments. | Private Equity Investor | - |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Directeur/Membre du Conseil | - |
Crosslanes Holding AB | Directeur/Membre du Conseil | - |
TargED Biopharmaceuticals BV
 TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis | Directeur/Membre du Conseil | - |
HVentures Capital i AB
 HVentures Capital i AB Investment ManagersFinance Provides private equity fund services | Corporate Officer/Principal | - |
HVentures Capital II AB
 HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund | Corporate Officer/Principal | - |
Anciens postes connus de Roger Franklin
| Sociétés | Poste | Fin |
|---|---|---|
Liberum Capital Ltd.
 Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/10/2018 |
SAGA Diagnostics AB
 SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Corporate Officer/Principal | - |
Formation de Roger Franklin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Abliva AB
 Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Liberum Capital Ltd.
Liberum Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
SAGA Diagnostics AB
SAGA Diagnostics AB BiotechnologyHealth Technology Operates as a biotechnology company which engages in ultrasensitive molecular diagnostic tests for cancer treatment and surveillance | Health Technology |
Hadean Ventures AS
Hadean Ventures AS Investment ManagersFinance Hadean Ventures invests in life science companies across Europe with a particular focus on the Nordic region. The firm targets companies operating in the fields of pharmaceuticals, biotech, medical technology, diagnostics, and digital health. The firm provides financing for early stage capital requirements and also makes co-investments. | Finance |
Gesynta Pharma AB
Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures novel oral treatments for patients with chronic inflammatory conditions | Health Technology |
HVentures Capital i AB
HVentures Capital i AB Investment ManagersFinance Provides private equity fund services | Finance |
TargED Biopharmaceuticals BV
TargED Biopharmaceuticals BV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops biological drugs to improve treatment of thrombosis | Health Technology |
HVentures Capital II AB
HVentures Capital II AB Investment ManagersFinance Functions as a venture capital fund | Finance |
Crosslanes Holding AB |
